Trimi Health
Status: Verified · 2 row(s) on file · checked 2026-09-12
A data file, not a finished review: the prices below are first-party captures from the provider’s own live pages, with intro/renewal, membership, and offer conditions stored on each row with their source and check date. Each figure was read on Trimi Health’s own pages on the date shown; a verified figure expires after 90 days and is rechecked, and any condition attached to a price (a promotion, a prepaid term, a refund rule) is recorded on the row.
First-party verified pricing on file · semaglutide, tirzepatide
- Semaglutide
- from $99/mo — 12-mo plan; ($175 month-to-month); flat at every dose; $0 membership
- Tirzepatide
- from $125/mo — 12-mo plan; ($235 month-to-month); flat at every dose; $0 membership
- Provenance
- trytrimi.com · checked 2026-09-12
Provider scorecard — the fields the sprint fills
| Pharmacy on file | VialsRx; GreenwichRx (named on an earlier read); plan page 2026-09-12 says 'a licensed compounding pharmacy, if prescribed' |
| Pharmacy type | 503A |
| States served | queued — unconfirmed coverage keeps state pages noindexed |
| Membership · consult fee | $0 · $0 |
| Dose-change policy | flat all doses |
| Cancellation terms | refund in full only if found ineligible |
| Shipping | included |
| Intro price (first month/period) | — |
| Medication included in price | yes |
| Offer conditions on file | term plans prepaid; refund in full only if found ineligible at provider review; stopping renewal does not end the current commitment |
| Offer expiry / scheduled recheck | — |
| Support-response test | pending — standardized three-question timed email test, per the sprint |
| Cancellation walkthrough | pending — scripted cancel-and-document test, per the sprint |
| Update history | row verified/recorded 2026-09-12 · file regenerated 2026-09-20 |
Watch-outs recorded by trackers
- Plan page read 2026-09-11 and 2026-09-12: $175 monthly, $435 quarterly ($145/mo), $720 per six months ($120/mo), $1188 yearly ($99/mo); 'Medication + supplies, provider access, shipping included'; 'same price at every prescribed dose'; no enrollment, consultation or shipping fees; 24/7 messaging; payment collected at checkout before provider review and refunded in full if treatment is not appropriate (refund policy 2026-06-17); conditional six-month money-back promise requiring logged weigh-ins; code 50OFF takes $50 off a first month (we do not publish codes — recorded as a fact); laboratory review not advertised
- Tirzepatide page re-read 2026-09-20: 12-month '$125/month equivalent', '$1,500 billed yearly' / '$1,500 billed upfront', 'Monthly equivalent, not monthly installments', '12-month commitment', 'Renews every year'; 6-month $175/mo ($1,050 billed every 6 months); 3-month $199/mo ($597 every 3 months); monthly $235; 'Same price at every prescribed dose'; refunds: full refund if treatment is not appropriate, otherwise a 'conditional 6-month money-back policy'; 'You can stop future renewal, but that does not end your current plan commitment'. | Earlier: Plan page read 2026-09-11 and 2026-09-12: $235 monthly, $597 quarterly ($199/mo), $1050 per six months ($175/mo), $1500 yearly ($125/mo); 'Medication + supplies, provider access, shipping included'; 'same price at every prescribed dose'; no enrollment, consultation or shipping fees; 24/7 messaging; payment collected at checkout before provider review and refunded in full if treatment is not appropriate (refund policy 2026-06-17); conditional six-month money-back promise requiring logged weigh-ins; code 50OFF takes $50 off a first month (we do not publish codes — recorded as a fact); laboratory review not advertised
What we have not verified
The standing (non-promo) rate at every dose; whether the figure is all-inclusive; the dispensing pharmacy and its 503A/503B status; state availability; cancellation terms. Until those are recorded first-party, Trimi Health appears in ranked tables at its reported figure with a Reported chip, never a Verified one — the same rule applied to every program here, including every partner program — placements are labeled “Editor’s Pick” and disclosed.
No outbound link: we have not confirmed this program's canonical domain first-party, and we do not guess URLs.